Providing concise information on the new regulation, and explores the opportunity that the MDR provides for accelerating the phase-out harmful chemicals found in some medical devices.
Report | Non-toxic healthcare: Alternatives to phthalates and bisphenol A in medical devices (31/12/2014)
Providing evidence of potential hazards that endocrine disrupting chemicals pose to human health and the environment. This also presents an analysis of safer alternatives available on the market and calls for a phase out of phthalates and bisphenol A (BPA) in medical devices.
Towards non-toxic healthcare (21/03/2013)
Final report of the lunch seminar organised by HCWH Europe in the European Parliament to raise awareness amongst policy makers on the hazard of Endocrine Disrupting Chemicals (EDCs) and Carcinogenic and Mutagenic Chemicals (CMRs) contained in medical devices.
Report | Healthy & sustainable flooring: Choosing resilient flooring for the European healthcare sector (09/2012) [Available in German, Spanish, French, or Portuguese]
Enabling decision-makers in healthcare to set decision criteria for choosing resilient flooring in European Hospitals.
The weight of the evidence on DEHP: Exposures are a cause for concern especially during medical care (16/03/2009)
Several government assessments conclude that DEHP exposure is of concern to some patient populations, especially the vulnerable. Some studies recommend specific action to reduce DEHP exposure in healthcare.
Guide | Choosing safer products and chemicals: Implementing chemicals policy in healthcare (05/2008)
How to: make and implement a comprehensive chemicals policy in healthcare, eliminate the use of toxic chemicals, create safer workplaces, ecosystems, and communities, and reduce long term costs and liabilities.
PVC/DEHP phase-out is possible anywhere in Europe: Model hospitals show how to succeed (12/2007)
This factsheet describes the common lessons learned from across Europe to show how PVC phase-out is possible, whatever the political and economic climate. It also lists hospitals which are phasing out PVC and the devices with which they are having most success.
Why healthcare is moving away from the hazardous plastic Polyvinyl Chloride (PVC) (06/04/2006)
PVC or “vinyl” can adversely impact human health and the environment, the reproductive toxicant DEHP is used to make it flexible, but it leaches out of PVC medical devices, exposing patients. Many hospitals now seek alternatives to PVC.
Report | Preventing harm from phthlates: Avoiding PVC in hospitals (06/2004)
Across the European Union hospital patients are unnecessarily being exposed to the phthalate DEHP from PVC medical devices. In 2004, HCWH tested 48 common medical devices used in European hospitals for the presence of DEHP. 39 out of 48 products contained between 17%-41% DEHP by weight.
- Webinar | Medical Devices Regulation – Heading in the right direction? (10/09/2018)
- Webinar | The new medical devices regulation - An engine for EDC substitution? (09/11/2016)
- Webinar | PVCFree blood bag webinar (10/2015)
- Podcast | SAICM ICCM4 (09/2015)
- Webinar | EDCs in healthcare (24/09/2014)